The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Association Between Timeliness of Reperfusion Therapy and Clinical Outcomes in ST-Elevation Myocardial Infarction
Abstract
CONTEXT: Guidelines emphasize the importance of rapid reperfusion of patients with ST-elevation myocardial infarction (STEMI) and specify a maximum delay of 30 minutes for fibrinolysis and 90 minutes for primary percutaneous coronary intervention (PPCI). However, randomized trials and selective registries are limited in their ability to assess the effect of timeliness of reperfusion on outcomes in real-world STEMI patients. OBJECTIVES: To obtain a complete interregional portrait of contemporary STEMI care and to investigate timeliness of reperfusion and outcomes. DESIGN, SETTING, AND PATIENTS: Systematic evaluation of STEMI care for 6 months during 2006-2007 in 80 hospitals that treated more than 95% of patients with acute myocardial infarction in the province of Quebec, Canada (population, 7.8 million). MAIN OUTCOME MEASURES: Death at 30 days and at 1 year and the combined end point of death or hospital readmission for acute myocardial infarction or congestive heart failure at 1 year by linkage to Quebec's medicoadministrative databases. RESULTS: Of 1832 patients treated with reperfusion, 392 (21.4%) received fibrinolysis and 1440 (78.6%) received PPCI. Fibrinolysis was untimely (>30 minutes) in 54% and PPCI was untimely (>90 minutes) in 68%. Death or readmission for acute myocardial infarction or heart failure at 1 year occurred in 13.5% of fibrinolysis patients and 13.6% of PPCI patients. When the 2 treatment groups were combined, patients treated outside of recommended delays had an adjusted higher risk of death at 30 days (6.6% vs 3.3%; odds ratio [OR], 2.14; 95% confidence interval [CI], 1.21-3.93) and a statistically nonsignificant increase in risk of death at 1 year (9.3% vs 5.2%; OR, 1.61; 95% CI, 1.00-2.66) compared with patients who received timely treatment. Patients treated outside of recommended delays also had an adjusted higher risk for the combined outcome of death or hospital readmission for congestive heart failure or acute myocardial infarction at 1 year (15.0% vs 9.2%; OR, 1.57; 95% CI, 1.08-2.30). At the regional level, after adjustment, each 10% increase in patients treated within the recommended time was associated with a decrease in the region-level odds of overall 30-day mortality (OR, 0.80; 95% CI, 0.65-0.98). CONCLUSION: Among patients in Quebec with STEMI, reperfusion delivered outside guideline-recommend delays was associated with significantly increased 30-day mortality, a statistically nonsignificant increase in 1-year mortality, and significantly increased risk of the composite of mortality or readmission for acute myocardial infarction or heart failure at 1 year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authors/Task Force Members, Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn416 · Cited by 2,310
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911
Scientific evidence underlying the ACC/AHA clinical practice guidelines.
Tricoci, P. (2009) · JAMA · doi:10.1001/jama.2009.205 · Cited by 908
Cepeda, M. S. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg115 · Cited by 859 · cited 1×
“Due to the possibility of biased multivariate effect estimates in nonexperimental studies when the ratio of outcomes to potential confounders is low, a matched propensity score analysis was used as a sensitivity analysis of the effect of treatment timeliness.(21,22) The propensityscorewascalculatedbyusing18variables(a…”
MethodStukel, T. A., Fisher, E. S., Wennberg, D. E., Alter, D. A., Gottlieb, D. J., & Vermeulen, M. J. (2007) · JAMA · doi:10.1001/jama.297.3.278 · Cited by 786
Optimal Matching for Observational Studies
Rosenbaum, P. R. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478868 · Cited by 715
Rathore, S. S., Curtis, J. P., Chen, J., Wang, Y., Nallamothu, B. K., Epstein, A. J., Krumholz, H. M., & for the National Cardiovascular Data Registry (2009) · BMJ · doi:10.1136/bmj.b1807 · Cited by 483
Kalla, K., Christ, G., Karnik, R., Malzer, R., Norman, G., Prachar, H., Schreiber, W., Unger, G., Glogar, H. D., Kaff, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.586198 · Cited by 374
Danchin, N., Coste, P., Ferrières, J., Steg, P.-G., Cottin, Y., Blanchard, D., Belle, L., Ritz, B., Kirkorian, G., Angioi, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.762765 · Cited by 325
Eagle, K. A., Nallamothu, B. K., Mehta, R. H., Granger, C. B., Steg, P. G., Van de Werf, F., Lopez-Sendon, J., Goodman, S. G., Quill, A., Fox, K. A. A., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn069 · Cited by 270
External Validity of Clinical Trials in Acute Myocardial Infarction
Steg, P. G. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.68 · Cited by 269
Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction.
Levy, A., Tamblyn, R. M., FITCHETT, D. H., McLeod, P. J., & Hanley, J. A. (1999) · PubMed · Cited by 191
Austin, P. C. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1674 · Cited by 187
Huynh, T., Perron, S., O'Loughlin, J., Joseph, L., Labrecque, M., Tu, J. V., & Théroux, P. (2009) · Circulation · doi:10.1161/circulationaha.108.793745 · Cited by 184
Nallamothu, B. K., Wang, Y., Magid, D. J., McNamara, R. L., Herrin, J. S., Bradley, E. H., Bates, E., Pollack, C. V., & Krumholz, H. M. (2006) · Circulation · doi:10.1161/circulationaha.105.578195 · Cited by 105
Wiviott, S. D., Morrow, D. A., Frederick, P. D., Giugliano, R. P., Gibson, C. M., McCabe, C. H., Cannon, C. P., Antman, E. M., & Braunwald, E. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.045 · Cited by 98
Mehta, R. H., Bufalino, V. J., Pan, W., Hernandez, A. F., Cannon, C. P., Fonarow, G. C., & Peterson, E. D. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.01.010 · Cited by 91
Patient Registries of Acute Coronary Syndrome
González, I. F., Marsal, J. R., Mitjavila, F., Parada, A., Ribera, A., Cascant, P., Soriano, N., Sanchez, P. L., Arós, F., Heras, M., et al. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.844399 · Cited by 74
Krumholz, H. M. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.916601 · Cited by 73
So, D. Y. F., Ha, A. C. T., Turek, M. A., Maloney, J. P., Higginson, L., Davies, R. F., Ryan, S. C., & May, M. R. L. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.069 · Cited by 54
Westfall, J. M., Kiefe, C. I., Weissman, N., Goudie, A., Centor, R. M., Williams, O. D., & Allison, J. J. (2008) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-8-22 · Cited by 39
Cited by
WRITING COMMITTEE MEMBERS*, O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,725
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C., Fesmire, F. M., Franklin, B. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.019 · Cited by 2,625
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823a5596 · Cited by 632
Metadata
- Authors
- Lambert, L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-06-02
- Volume
- 303
- Issue
- 21
- Pages
- 2148
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2039828518
- Cited by
- 262
- References
- 21
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.